RHYTHM PHARMACEUTICALS, INC. Operating Lease, Expense
RHYTHM PHARMACEUTICALS, INC. (RYTM) reported Operating Lease, Expense of $302.00 thousand for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2024-11-06
- RHYTHM PHARMACEUTICALS, INC. operating lease, expense for the quarter ending 2024-09-30 was $302.00K, a 7.86% increase year-over-year.
- RHYTHM PHARMACEUTICALS, INC. operating lease, expense for the quarter ending 2024-06-30 was $272.00K, a 6.53% decline year-over-year.
- RHYTHM PHARMACEUTICALS, INC. operating lease, expense for the quarter ending 2023-12-31 was -$316.00K.
- RHYTHM PHARMACEUTICALS, INC. operating lease, expense for the quarter ending 2023-09-30 was $280.00K.
- RHYTHM PHARMACEUTICALS, INC. operating lease, expense for fiscal 2023 was $551.00K, a 0.00% change from fiscal 2022.
- RHYTHM PHARMACEUTICALS, INC. operating lease, expense for fiscal 2022 was $551.00K, a 0.00% change from fiscal 2021.
- RHYTHM PHARMACEUTICALS, INC. operating lease, expense for fiscal 2021 was $551.00K, a 0.00% change from fiscal 2020.
- RHYTHM PHARMACEUTICALS, INC. operating lease, expense for fiscal 2020 was $551.00K, a 12.40% decline from fiscal 2019.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month |
|---|---|---|---|---|
| 2024-09-30 | $302.00K 10-Q · filed 2024-11-06 | $574.00K derived: sum of 2 quarters · filed 2024-11-06 | $908.00K 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $272.00K 10-Q · filed 2024-08-06 | $606.00K 10-Q · filed 2024-08-06 | ||
| 2023-12-31 | -$316.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$36.00K derived: sum of 2 quarters · filed 2024-11-06 | $255.00K derived: sum of 3 quarters · filed 2024-11-06 | $551.00K 10-K · filed 2024-02-29 |
| 2023-09-30 | $280.00K 10-Q · filed 2024-11-06 | $571.00K derived: sum of 2 quarters · filed 2024-11-06 | $867.00K 10-Q · filed 2024-11-06 | |
| 2023-06-30 | $291.00K 10-Q · filed 2024-08-06 | $587.00K 10-Q · filed 2024-08-06 | ||
| 2022-12-31 | $551.00K 10-K · filed 2024-02-29 | |||
| 2021-12-31 | $551.00K 10-K · filed 2024-02-29 | |||
| 2020-12-31 | $137.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $275.00K derived: sum of 2 quarters · filed 2023-03-01 | $413.00K derived: sum of 3 quarters · filed 2023-03-01 | $551.00K 10-K · filed 2023-03-01 |
| 2020-09-30 | $138.00K 10-Q · filed 2020-11-02 | $276.00K derived: sum of 2 quarters · filed 2020-11-02 | $414.00K 10-Q · filed 2020-11-02 | $552.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $138.00K 10-Q · filed 2020-08-03 | $276.00K 10-Q · filed 2020-08-03 | $414.00K derived: sum of 3 quarters · filed 2022-03-01 | $552.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $138.00K 10-Q · filed 2020-05-04 | $276.00K derived: sum of 2 quarters · filed 2022-03-01 | $414.00K derived: sum of 3 quarters · filed 2022-03-01 | $591.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $138.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $276.00K derived: sum of 2 quarters · filed 2022-03-01 | $453.00K derived: sum of 3 quarters · filed 2022-03-01 | $629.00K 10-K · filed 2022-03-01 |
| 2019-09-30 | $138.00K 10-Q · filed 2020-11-02 | $315.00K derived: sum of 2 quarters · filed 2020-11-02 | $491.00K 10-Q · filed 2020-11-02 | $654.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $177.00K 10-Q · filed 2020-08-03 | $353.00K 10-Q · filed 2020-08-03 | $516.00K derived: sum of 3 quarters · filed 2021-03-01 | $606.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $177.00K 10-Q · filed 2020-05-04 | $339.00K derived: sum of 2 quarters · filed 2021-03-01 | $429.00K derived: sum of 3 quarters · filed 2021-03-01 | $483.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $162.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $252.00K derived: sum of 2 quarters · filed 2021-03-01 | $306.00K derived: sum of 3 quarters · filed 2021-03-01 | $359.00K 10-K · filed 2021-03-01 |
| 2018-09-30 | $90.00K 10-Q · filed 2019-11-01 | $144.00K derived: sum of 2 quarters · filed 2019-11-01 | $197.00K 10-Q · filed 2019-11-01 | |
| 2018-06-30 | $54.00K 10-Q · filed 2019-07-29 | $107.00K 10-Q · filed 2019-07-29 | ||
| 2017-12-31 | $215.00K 10-K · filed 2020-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |